| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Leslie Citrome, Ai Ota, Kazuhiro Nagamizu, Pamela Perry, Emmanuelle Weiller, Ross A Bake. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology. vol 31. issue 4. 2017-11-27. PMID:26963842. |
the effect of brexpiprazole (opc-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. |
2017-11-27 |
2023-08-13 |
Not clear |
| Leslie Citrome, Ai Ota, Kazuhiro Nagamizu, Pamela Perry, Emmanuelle Weiller, Ross A Bake. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology. vol 31. issue 4. 2017-11-27. PMID:26963842. |
the aim of this study was to explore the effects of brexpiprazole and aripiprazole on efficacy, cognitive functioning, and safety in patients with acute schizophrenia. |
2017-11-27 |
2023-08-13 |
Not clear |
| Leslie Citrome, Ai Ota, Kazuhiro Nagamizu, Pamela Perry, Emmanuelle Weiller, Ross A Bake. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology. vol 31. issue 4. 2017-11-27. PMID:26963842. |
patients who would benefit from hospitalization/continued hospitalization for acute relapse of schizophrenia were enrolled and randomized (2 : 1) to target doses of open-label brexpiprazole 3 mg/day or aripiprazole 15 mg/day for 6 weeks. |
2017-11-27 |
2023-08-13 |
Not clear |
| Leslie Citrome, Ai Ota, Kazuhiro Nagamizu, Pamela Perry, Emmanuelle Weiller, Ross A Bake. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology. vol 31. issue 4. 2017-11-27. PMID:26963842. |
patients treated with brexpiprazole (n=64) or aripiprazole (n=33) showed reductions in symptoms of schizophrenia as assessed by positive and negative syndrome scale total score (-22.9 and -19.4, respectively). |
2017-11-27 |
2023-08-13 |
Not clear |
| Leslie Citrome, Ai Ota, Kazuhiro Nagamizu, Pamela Perry, Emmanuelle Weiller, Ross A Bake. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology. vol 31. issue 4. 2017-11-27. PMID:26963842. |
clinically relevant improvements in psychopathology were observed in patients with acute schizophrenia treated with brexpiprazole or aripiprazole. |
2017-11-27 |
2023-08-13 |
Not clear |
| Joseph P McEvoy, Robert Risinger, Serhiy Mykhnyak, Yangchun Du, Chih-Chin Liu, Arielle D Stanford, Peter J Weide. Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia. The Journal of clinical psychiatry. vol 78. issue 8. 2017-11-20. PMID:28937706. |
durability of therapeutic response with long-term aripiprazole lauroxil treatment following successful resolution of an acute episode of schizophrenia. |
2017-11-20 |
2023-08-13 |
Not clear |
| Joseph P McEvoy, Robert Risinger, Serhiy Mykhnyak, Yangchun Du, Chih-Chin Liu, Arielle D Stanford, Peter J Weide. Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia. The Journal of clinical psychiatry. vol 78. issue 8. 2017-11-20. PMID:28937706. |
to evaluate durability of therapeutic effect of long-term treatment with aripiprazole lauroxil in patients with schizophrenia following successful treatment of an acute psychotic episode. |
2017-11-20 |
2023-08-13 |
Not clear |
| b' Cristiano Carlone, Enrico Pompili, Cristiana Silvestrini, Giuseppe Nicol\\xc3\\xb. Aripiprazole once-monthly as treatment for psychosis in Turner syndrome: literature review and case report. Rivista di psichiatria. vol 51. issue 4. 2017-10-26. PMID:27727262.' |
its efficacy and non-inferiority to oral aripiprazole have been demonstrated in preventing relapse in patients with schizophrenia. |
2017-10-26 |
2023-08-13 |
Not clear |
| b' Cristiano Carlone, Enrico Pompili, Cristiana Silvestrini, Giuseppe Nicol\\xc3\\xb. Aripiprazole once-monthly as treatment for psychosis in Turner syndrome: literature review and case report. Rivista di psichiatria. vol 51. issue 4. 2017-10-26. PMID:27727262.' |
experience with oral aripiprazole and the current availability of the long-acting formulation suggest a potential benefit in a variety of clinical scenarios and therefore consideration as a treatment option in the treatment of schizophrenia and psychotic symptoms in several disease like ts. |
2017-10-26 |
2023-08-13 |
Not clear |
| Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin, Timothy Peters-Strickland, Maud Beillat, Anna-Greta Nylander, Peter Hertel, Simon Nitschky Schmidt, Anders Ettrup, Anna Eramo, Karina Hansen, Dieter Nabe. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study. PloS one. vol 12. issue 8. 2017-10-23. PMID:28837593. |
relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: a post-hoc analysis of the qualify study. |
2017-10-23 |
2023-08-13 |
Not clear |
| Krithika Rajagopalan, David Trueman, Lydia Crowe, Daniel Squirrell, Antony Loebe. Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia. PharmacoEconomics. vol 34. issue 7. 2017-10-13. PMID:27067724. |
cost-utility analysis of lurasidone versus aripiprazole in adults with schizophrenia. |
2017-10-13 |
2023-08-13 |
Not clear |
| Enrico Biagi, Enrico Capuzzi, Fabrizia Colmegna, Alessandra Mascarini, Giulia Brambilla, Alessandra Ornaghi, Jacopo Santambrogio, Massimo Cleric. Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly. Advances in therapy. vol 34. issue 5. 2017-10-10. PMID:28382557. |
long-acting injectable antipsychotics in schizophrenia: literature review and practical perspective, with a focus on aripiprazole once-monthly. |
2017-10-10 |
2023-08-13 |
Not clear |
| Marjie L Hard, Richard J Mills, Brian M Sadler, Ryan Z Turncliff, Leslie Citrom. Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia. Journal of clinical psychopharmacology. vol 37. issue 3. 2017-08-04. PMID:28350572. |
aripiprazole lauroxil: pharmacokinetic profile of this long-acting injectable antipsychotic in persons with schizophrenia. |
2017-08-04 |
2023-08-13 |
Not clear |
| Marjie L Hard, Richard J Mills, Brian M Sadler, Ryan Z Turncliff, Leslie Citrom. Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia. Journal of clinical psychopharmacology. vol 37. issue 3. 2017-08-04. PMID:28350572. |
aripiprazole lauroxil is an extended-release prodrug of aripiprazole for intramuscular injection, approved for schizophrenia treatment. |
2017-08-04 |
2023-08-13 |
Not clear |
| Zahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, Ross A Baker, Peter Hertel, Anna Eramo, Na Jin, Pamela Perry, Raymond Sanchez, Robert D McQuade, John M Kan. Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores. Journal of clinical psychopharmacology. vol 37. issue 3. 2017-08-04. PMID:28383362. |
aripiprazole once-monthly in the treatment of acute psychotic episodes in schizophrenia: post hoc analysis of positive and negative syndrome scale marder factor scores. |
2017-08-04 |
2023-08-13 |
Not clear |
| Zahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, Ross A Baker, Peter Hertel, Anna Eramo, Na Jin, Pamela Perry, Raymond Sanchez, Robert D McQuade, John M Kan. Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores. Journal of clinical psychopharmacology. vol 37. issue 3. 2017-08-04. PMID:28383362. |
in a previously published 12-week randomized, double-blind, placebo-controlled clinical trial of patients with schizophrenia experiencing an acute psychotic episode, aripiprazole once-monthly 400 mg (aom 400) produced significantly greater improvement than placebo on the primary endpoint, positive and negative syndrome scale (panss) total score at week 10. |
2017-08-04 |
2023-08-13 |
Not clear |
| L San, G Estrada, N Oudovenko, E Viet. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. BMC psychiatry. vol 17. issue 1. 2017-07-31. PMID:28376877. |
rationale and design of the placid study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus im aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. |
2017-07-31 |
2023-08-13 |
Not clear |
| Chris Cameron, Jacqueline Zummo, Dharmik N Desai, Christine Drake, Brian Hutton, Ahmed Kotb, Peter J Weide. Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. vol 20. issue 7. 2017-07-24. PMID:28712616. |
aripiprazole lauroxil compared with paliperidone palmitate in patients with schizophrenia: an indirect treatment comparison. |
2017-07-24 |
2023-08-13 |
Not clear |
| Chris Cameron, Jacqueline Zummo, Dharmik N Desai, Christine Drake, Brian Hutton, Ahmed Kotb, Peter J Weide. Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. vol 20. issue 7. 2017-07-24. PMID:28712616. |
aripiprazole lauroxil (al) is a long-acting injectable atypical antipsychotic recently approved for treatment of schizophrenia on the basis of a large-scale trial of two doses of al versus placebo. |
2017-07-24 |
2023-08-13 |
Not clear |
| Timothy Peters-Strickland, Cathy Zhao, Pamela P Perry, Anna Eramo, Phyllis M Salzman, Robert D McQuade, Brian R Johnson, Raymond Sanche. Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics. CNS spectrums. vol 21. issue 6. 2017-06-29. PMID:27531181. |
effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics. |
2017-06-29 |
2023-08-13 |
Not clear |